Compare OLMA & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OLMA | SMBK |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 887.9M |
| IPO Year | 2020 | 2000 |
| Metric | OLMA | SMBK |
|---|---|---|
| Price | $10.90 | $50.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $44.89 | $43.17 |
| AVG Volume (30 Days) | ★ 993.2K | 112.8K |
| Earning Date | 05-08-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | 15.00 | ★ 39.25 |
| EPS | N/A | ★ 1.77 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.59 |
| Revenue Next Year | N/A | $10.30 |
| P/E Ratio | ★ N/A | $28.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.36 | $33.01 |
| 52 Week High | $36.26 | $54.14 |
| Indicator | OLMA | SMBK |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 49.73 |
| Support Level | $10.71 | $40.28 |
| Resistance Level | $12.37 | $54.14 |
| Average True Range (ATR) | 0.59 | 1.15 |
| MACD | -0.04 | -0.43 |
| Stochastic Oscillator | 44.62 | 16.58 |
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.